Biovian is a Finnish CDMO dedicated to transforming scientific innovations into life-saving therapeutics. We provide premium services to biotech companies developing innovative gene therapies and biopharmaceuticals. With 20 years of operational experience, strong scientific expertise, a deep understanding of regulatory requirements, and a commitment to quality and GMP compliance, we empower our clients to bring new therapies to patients worldwide.
Our One-Stop-Shop CDMO services include the production of:
- Viral vectors (AAV, adenovirus, etc.)
As well as:
Biovian thrives on building long-term partnerships and delivering cost-effective solutions. Our expert teams with profound knowledge in Process Development, Technical Transfer, GMP manufacturing, and Analytical Development are committed to taking your project from laboratory bench to the clinic.